جستجوی استاد راهنمای دانشگاهی

Leong Siew Lianمشاهده پروفایل

مدرس

• Clinical Pharmacy
• Pharmacy Practice
• Oncology
• +۴ مورد دیگر

Dr. Leong Siew Lian is a registered pharmacist and lecturer at the School of Pharmacy, Monash University Malaysia. She holds a PhD from Monash University, a Master of Clinical Pharmacy from Universiti Kebangsaan Malaysia, and a Bachelor of Pharmacy (Honors) from Universiti Malaya. Her research focuses on clinical pharmacy, oncology, medication safety, and evidence synthesis, aiming to improve treatment outcomes and quality of life for cancer patients. She has supervised multiple research projects at Cyberjaya University College of Medical Sciences and contributed to initiatives like the BBAC Non-Communicable Disease project in ASEAN. Dr. Leong has been awarded the 2022 Strategic Research Fund grant and has organized workshops on health economic evaluation. Her work aligns with UN Sustainable Development Goals related to health and well-being. Education: PhD (Monash University, 2018), MSc Clinical Pharmacy (UKM, 2010), BPharm (UM, 2004). Research Interests: Clinical pharmacy practice, oncology, medication safety, evidence synthesis, and healthcare workforce optimization. Key areas include pharmacist-led interventions in pain management, pharmacogenomics education, and cost-effectiveness of public health strategies. Professional Activities: Active in organizing workshops on health economics and contributing to interdisciplinary projects addressing healthcare challenges in Southeast Asia.

• Radiopharmaceutical Chemistry
• Inorganic Coordination Chemistry
• Optical Imaging
• +۳ مورد دیگر

Dr. Manja Kubeil is a Researcher at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR), specializing in radiopharmaceutical chemistry and inorganic coordination chemistry. Her research focuses on developing advanced chelating ligands (e.g., bispidine derivatives) for targeted cancer diagnostics and therapy, with emphasis on isotopes like copper-64, lutetium-177, and actinium-225. She pioneers nanogel-based drug carriers and immunoconjugates for theranostic applications. Research interests span Radiopharmaceutical Development: Designing stable metal complexes for precision oncology. Nanomaterial Applications: Utilizing nanogels and nanoparticles for drug delivery and imaging. Molecular Targeting: Creating tumor-specific probes for Fibroblast Activation Protein (FAP)-expressing cancers. Her recent publications demonstrate a strong focus on bispidine ligands for multi-isotope chelation, nanotheranostics, and immuno-PET applications. Collaborative work includes innovations in CAR T-cell therapy integration with radiopharmaceuticals. No awards, students, or part-time affiliations are documented. Extensive collaborations are evident through co-authorship networks spanning Germany, Italy, and Japan.

Julien Boudonمشاهده پروفایل

مدرس

• Nanoparticles
• Nanomedicine
• Biomedical Imaging
• +۵ مورد دیگر

Julien Boudon is a Lecturer-researcher at the University of Burgundy Europe (UBE), attached to the Interdisciplinary Carnot Laboratory of Burgundy (ICB, UMR 6303) since September 2011. He serves as deputy director of the Nanosciences department of the ICB and leads the BH2N team. His academic affiliation includes being co-responsible for the M2 Chemical Controls and Analysis (CAC) program. Dr. Boudon's research focuses on (Bio-)Hybrid Nanoparticles & Nanostructures, specifically developing functionalization approaches through step-by-step organic grafting of metal oxide nanoparticles. His work addresses critical questions of purification and characterization of nanohybrids developed for biomedical applications, including contrast agents for medical imaging and therapeutic vectors. His research bridges chemistry, materials science, and biomedical engineering to create innovative diagnostic and therapeutic solutions. His publication record shows consistent output in nanomedicine and materials science, with particular emphasis on gold and iron oxide nanoparticles for medical applications. The research trends indicate progression from fundamental nanoparticle characterization to increasingly complex biomedical applications, with growing emphasis on translational research that bridges laboratory findings to clinical applications. 3 best poster awards Dr. Boudon actively supervises doctoral students and has mentored numerous Master's students and post-doctoral researchers. His research is supported by multiple projects including an ANER project (60 k€), EUR Croconano project (300 k€), and BQR uB NOTaThé (5 k€), along with participation in several collaborative initiatives such as PARI PharmacoImagerie, PARI Nano2Bio, and ANR UFO project. He serves as a reviewer for numerous journals and has been an expert for the ANR in multiple evaluation committees. He leads the BH2N team within the Interdisciplinary Carnot Laboratory of Burgundy and contributes significantly to the academic community through conference organization including NanoMed 2018, the 5th plenary days of the GdR B2i in 2022, and upcoming events in 2025.

Dhiraj Kumarمشاهده پروفایل

دانشگاهی

• Nanotherapeutics
• Nanotheranostics
• Nanomedicine
• +۷ مورد دیگر

Dhiraj Kumar is a Research Assistant Professor in Basic Sciences at the University of Minnesota, specializing in nanotherapeutics and nanotheranostics for personalized medicine. His research focuses on engineering nano/biomaterials and surface chemistry for various biomedical applications, with particular emphasis on polymeric and metallic/metal oxide nanoparticles for cancer targeting, drug/molecular delivery, tissue engineering, bone regeneration, diagnostics, and dental applications. Education: PhD in Co-functionalized gold nanoparticles for drug delivery application from Ulster University (2009-2012, awarded May 6, 2013) Masters in Nanobiotechnology from Amity University (2007-2009) MSc in Physical Chemistry from Delhi University (2004-2006) BS in Chemistry Honors from Hindu College, Delhi University (2001-2004) Research Interests: Dr. Kumar's research centers on developing and understanding nano/biomaterials for personalized medicine. His work spans nanotherapeutics and nanotheranostics, with a focus on engineering polymeric and metallic/metal oxide nanoparticles for cancer targeting, drug/molecular delivery, tissue engineering, bone regeneration, diagnostics, and dental applications. His fingerprint analysis shows strong expertise in nanoparticles (100%), gold nanoparticles (95%), surface science (65%), ethylene glycol (63%), ethyl methacrylate (61%), and photon-counting CT (50%). He investigates the properties of these materials and engineers their surface chemistry to optimize biomedical performance. Publication Trends: Dr. Kumar's recent publications (2023-2025) demonstrate a strong focus on dental applications of nanotechnology, with significant work on gold nanoparticles for imaging and cancer targeting. His research shows increasing emphasis on phosphate metabolism in dental caries, antimicrobial solutions for oral pathogens, and smart biomaterials for dental and orthopedic implants. The integration of spectral CT imaging with nanotheranostics represents a cutting-edge direction in his work, particularly for cancer detection and treatment monitoring. Projects and Grants: The Unrecognized Role of Phosphate-accumulating Bacteria (2021-2024) - as Researcher Novel Polymer Matrix for Dental Application Phase II (2018-2021) - as Researcher Collaborations: Dr. Kumar maintains extensive collaborations, particularly with Robert S. Jones (PI on multiple projects), Isha Mutreja, and other researchers in dental materials, nanotechnology, and biomedical imaging. His work shows strong connections between dental applications and cancer nanotheranostics, bridging these seemingly disparate fields through common nanomaterial platforms.

Isha Mutrejaمشاهده پروفایل

استاد

• Biomaterials
• Nanotechnology
• Nanomaterials
• +۶ مورد دیگر

Isha Mutreja is a Professor specializing in Cellular Mechanisms of Cancer , with extensive research contributions to biomaterials and tissue engineering. Her work focuses on nanostructured materials for medical applications, including cancer targeting, bone repair, and infection prevention in implants. PhD in Biomedical Engineering (2013) Principal Investigator in U.S. Department of Defense-funded project (2020-2024) Research interests encompass nanomaterials for cancer nanotheranostics , osteogenic scaffolds , and antimicrobial coatings . She explores polymer degradation mechanisms and biofabrication techniques to enhance implant integration. Recent publications highlight trends in gold nanoparticle conjugation for cancer targeting, Mg-based nanocomposites for bone regeneration, and ester group positioning in polymers to resist bacterial degradation. Key themes include biomimetic design , dual-function scaffolds , and 3D bioprinting of tissue models. Her work aligns with UN Sustainable Development Goals for Biomedical Innovation and Healthcare Advancement , particularly in materials science for implantable medical devices. Current projects involve bioinspired acellular strategies to optimize skin-implant interfaces, with collaborations across bioengineering, materials science, and dentistry disciplines.

Shukun Liمشاهده پروفایل

پژوهشگر ارشد

• Polymer Chemistry
• Peptide Chemistry
• Tumor Immunotherapy
• +۷ مورد دیگر

Shukun Li is a postdoctoral researcher at the Department of Chemical Engineering and Chemistry , Eindhoven University of Technology (TU/e), affiliated with the Bio-Organic Chemistry group and the Institute for Complex Molecular Systems (ICMS). Her work focuses on polymer/peptide-based nanomaterials for cancer immunotherapy and photothermal/photonodynamic therapies. PhD from Institute of Process Engineering, University of Chinese Academy of Sciences (2021) International Postdoctoral Exchange Fellowship (2021) NSFC Young Scientists Grant (2022) Marie Curie Postdoctoral Fellowship (2023) Research spans nanodrug morphology engineering , tumor-targeted delivery , and immune system modulation . Recent publications highlight her work on: pH-responsive nanosheets for combined PDT/immunotherapy shape-controlled nanoparticles for enhanced photothermal effects biocompatible ICG nanoparticle systems Scientific Awards : Marie Curie Postdoctoral Fellowships NSFC Young Scientists Program International Postdoctoral Exchange Fellowship Her projects receive funding from MSCA, Dutch Ministry of Education (Gravitation Program), ERC, and NSFC. Collaborations include Xuehai Yan (Chinese Academy of Sciences) and Jan van Hest's group (TU/e).

Chun Xuمشاهده پروفایل

پژوهشگر ارشد

• Nanomaterials
• Biomaterials
• Stem Cell Research
• +۳ مورد دیگر

Dr. Chun Xu is an Honorary Senior Research Fellow at the School of Dentistry, The University of Queensland, and an affiliate of the Centre for Orofacial Regeneration, Reconstruction and Rehabilitation (COR3). His research focuses on nanomaterials, biomaterials, and regenerative medicine, particularly in dental and bone tissue engineering. Xu holds a PhD in Materials Science from The University of Queensland (2016) and has authored over 150 peer-reviewed publications. His work integrates nanotechnology with clinical applications, including drug delivery systems, stem cell therapy, and bioengineered scaffolds. Xu collaborates extensively with interdisciplinary teams to advance treatments for osteoarthritis, neurodegenerative diseases, and dental regeneration. His studies on mesoporous silica nanoparticles and photodynamic therapy highlight his expertise in translational biomedical research. Key research themes include: nanomaterials for bone regeneration, immunomodulatory drug delivery, and personalized bioengineered implants. Xu’s publications span high-impact journals like Nature Biomedical Engineering , Advanced Materials , and Biomaterials . Labs/Teams: Active contributor to the COR3 initiative, advancing interdisciplinary approaches in orofacial regeneration.

Forrest Kievitمشاهده پروفایل

دانشیار

• Biomedical Engineering
• Nanomedicine
• Nanotheranostics
• +۲ مورد دیگر

Forrest Kievit is an Associate Professor in Biological Systems Engineering at the University of Nebraska-Lincoln. His research develops nanoparticle-based delivery systems for brain cancer and traumatic brain injury treatments, focusing on improving therapeutic efficacy and targeted drug delivery. Education: Ph.D. Materials Science and Engineering, University of Washington (2011) B.S. Bioengineering, University of Washington (2007) Research Areas: Specializes in nanomedicine and nanotheranostics for neurological disorders, with particular expertise in nanoparticle design for crossing the blood-brain barrier and reducing neuroinflammation. Publications focus on nanoparticle applications in brain injury models, MRI-based tracking of nanotherapeutics, and clinical translation of nanomedicine. Recent work emphasizes optimizing nanoparticle retention in damaged brain tissue. Awards: UNL College of Engineering Excellence in Research (2019) Leads the Kievit Lab which develops nanoparticle-based medical technologies. Mentors graduate students and postdoctoral researchers in biomedical engineering.

Mathumai Kanapathipillaiمشاهده پروفایل

دانشیار

• Programmable nanotheranostics
• Polymer chemistry
• Biomineralization
• +۵ مورد دیگر

Dr. Mathumai Kanapathipillai is an Associate Professor in the Department of Mechanical Engineering at the University of Michigan-Dearborn, part of the College of Engineering and Computer Science. Her research focuses on programmable nanotheranostics, polymer chemistry, biomineralization, tissue engineering, and protein engineering. She holds a Ph.D. in Chemical and Biological Engineering from Iowa State University, an MSc from Arizona State University, and a BSc from the University of Peradeniya, Sri Lanka. Postdoctoral training included roles at Boston Children’s Hospital and the Wyss Institute at Harvard. Her work emphasizes drug delivery systems and nanoformulations for treating diseases like cancer, stroke, and neurodegenerative conditions. Recent grants include NIH-funded projects on mechanosensitive nanoformulations and an AHA grant targeting oxidative stress in NETosis. Key collaborations involve developing shear-activated nanoparticles and exosome-based therapies. Research highlights include ultrasound-responsive amyloid depots, thrombolytic nanoformulations, and exosome-coated drug carriers. Her articles span journals like Advanced Drug Delivery Reviews , Nature Communications , and Biomaterials , reflecting expertise in nanotechnology and biomedical applications.

Karen Altمشاهده پروفایل

مدرس ارشد

• Molecular Imaging
• Antibody Engineering
• Theranostics
• +۳ مورد دیگر

Dr Karen Alt is a Senior Lecturer at the Australian Centre for Blood Diseases, Monash University. She leads the NanoTheranostics Laboratory and specializes in antibody engineering, molecular imaging, and theranostic agent development. Her research focuses on fibrosis detection and imaging techniques for disease progression analysis. Dr Alt has contributed to over 51 publications and holds grants from the Australian Research Council and National Heart Foundation. Education: PhD in Biology (Anti-PSMA Antibody and Fragments for Prostate Cancer Diagnostic and Therapy) from Monash University (2011). Research Interests: Molecular imaging of fibrosis, theranostics, and antibody-based diagnostic tools. Her work integrates bacterial transpeptidase sortase and click chemistry for imaging and drug delivery. Key Projects: Includes the ARC Training Centre for Advanced Radiochemical Technologies (2024–2029) and Translational Kidney Fibrosis Imaging in Diabetes (2024–2025). Awards: ACBD Best Paper Award (2022), MBI Competition 2nd Place (2015), and multiple grant recognitions. Grants/Activities: Collaborates on projects like molecular imaging of cardiac fibrosis and high oxygen water in TBI studies. Active in peer review for NHMRC and journals like PLoS One and Molecular Pharmaceutics. Labs/Teams: Head of NanoTheranostics Lab; collaborates across disciplines in imaging and drug delivery systems.

Siew Li Teohمشاهده پروفایل

مدرس

• Health Economics and Outcomes Research
• Evidence-Based Medicine
• Palliative Care
• +۳ مورد دیگر

Dr. Siew Li Teoh is a Lecturer in the School of Pharmacy at Monash University Malaysia, specializing in Health Economics and Outcomes Research. She holds a Master of Pharmacy from the University of Strathclyde and completed her PhD in Health Economics and Outcomes Research at Monash University Malaysia. Dr. Teoh’s work focuses on maternal and child health, mental health, palliative care, and mindfulness interventions, with collaborative projects involving the World Health Organization, Hospis Malaysia, and Malaysia’s Ministry of Health. She actively contributes to evidence-based medicine through systematic reviews, meta-analyses, and qualitative studies. Her research portfolio includes pioneering studies on pharmacist-delivered interventions in pain management, breastfeeding support programs, and the economic burden of chronic diseases. Dr. Teoh leads the Contributing Factors and Impact of Burnout on Malaysian Pharmacists project (2023–2026) as Primary Chief Investigator, addressing workforce well-being in healthcare settings. She has also been awarded grants including the MUM High Impact Research Support Fund (2024) and the Early Career Research Grant (2023). Dr. Teoh’s academic activities extend to organizing workshops on systematic reviewing and discrete choice experiments. She has been featured in media discussions on breastfeeding support, loneliness mitigation through mindfulness, and public health trends. Her work aligns with UN Sustainable Development Goals, particularly in improving health equity and sustainable communities.

Shawn Xiaoyuan Chenمشاهده پروفایل

استاد

• Cancer Diagnostics and Therapeutics
• Nanomedicine
• Gene/Drug Delivery
• +۷ مورد دیگر

Professor Shawn Xiaoyuan Chen at the National University of Singapore (NUS) Yong Loo Lin School of Medicine holds the Nasrat Muzayyin Chair Professor in Diagnostic Radiology. His research spans cancer nanotheranostics , cardiovascular imaging , and ultrasensitive nanobiosensors , with a focus on clinical translation. PhD in Chemistry (1999), University of Idaho MS/BS in Chemistry (1996/1993), Nanjing University Key contributions include pioneering radiotheranostic agents like [177Lu]Lu-LNC1004 (FDA/HSA approved) and developing nanovaccine platforms for personalized cancer immunotherapy. His work on PROTAC-based nanomedicines and metabolic microenvironment remodeling has advanced targeted protein degradation and immunosuppression reversal. Scientific accolades include SNMMI Fellow , AIMBE Fellow , and Clarivate Highly Cited Researcher (5 consecutive years). He founded the journal Theranostics (IF 12.4) and serves on editorial boards of ACS Nano (IF 16.7) and J Nucl Med (IF 9.3).

Yongfeng Zhaoمشاهده پروفایل

استادیار

• Nanomaterials
• Polymer Chemistry
• Biomedical Imaging
• +۳ مورد دیگر

Dr. Yongfeng Zhao is an Assistant Professor in the Department of Chemistry, Physics, and Atmospheric Sciences at Jackson State University, affiliated with the College of Science, Engineering, and Technology. His research focuses on nanomaterials synthesis, surface functionalization, and biomedical applications. Key projects include developing multifunctional small molecules/polymers for material surface modification, green chemistry-based nanomaterials, and nanotheranostics for cancer imaging/therapy. Research Interests: Surface functionalization of materials using covalent immobilization techniques. Synthesis of organic/inorganic hybrid nanomaterials with controlled properties via green chemistry. Application of nanomaterials in biomedical imaging (e.g., PET, SPECT), diagnostics, and targeted therapy. Publications span nanomaterial design, cancer imaging, and nanoparticle synthesis. His work emphasizes translational research with clinical relevance, particularly in tumor targeting and theranostic platforms. Dr. Zhao’s lab is located in the John A. Peoples Science Building (Office 528B, Lab 507). He teaches General Chemistry, Organic Chemistry, and Polymer Chemistry.

Mhd Assadمشاهده پروفایل

پژوهشگر

• Nanomaterials
• Biomedical Engineering
• Optical Materials
• +۳ مورد دیگر

Mhd Assad is a Doctoral Student and Visitor (Doctoral Researcher) in the School of Chemical Engineering and Department of Chemistry and Materials Science. His research focuses on nanomaterials for biomedical and optical applications, including wound healing biomaterials, antibacterial nanotechnology, and stealth technologies. He holds a Dipl.ins., kemian tekniikka (Diploma in Chemical Engineering) awarded in 2019. Assad collaborates with institutions like the Masdar Institute of Science and Technology and the University of Sharjah. His work addresses global challenges such as antibiotic resistance and infectious disease management through innovative nanotechnology solutions. Education: Dipl.ins., kemian tekniikka (2019) Research Interests: Assad’s work spans nanomaterial synthesis, optical metamaterials, and biomedical nanotechnology. He explores applications in antimicrobial surfaces, drug delivery systems, and advanced functional coatings. His studies on nanostructured materials aim to bridge the gap between fundamental science and real-world technologies like wound healing materials and stealth coatings.

• Autophagy
• Cancer Biology
• Ovarian Cancer
• +۶ مورد دیگر

Ciro ISIDORO is a Full Professor at the Department of Health Sciences, University of Eastern Piedmont 'Amedeo Avogadro'. His research focuses on cancer biology, particularly autophagy mechanisms in ovarian cancer, lysosomal biology, and the therapeutic potential of natural compounds like resveratrol. He leads projects funded by institutions including the Regione Piemonte, MIUR, and the European Commission, investigating topics such as 3D organoid models, probiotic metabolites, and nanotheranostics. Key projects include: BANP: DA COMPILARE (2013-2016, European Commission) In vitro 3D organoid modeling of colon carcinoma (2017-2021, Università Piemonte Orientale) FFABR 2017- Fondo di finanziamento per le attività base di ricerca (2018-2021, MIUR) Rigenerazione tissutale ossea da cellule staminali gengivali (2017-2019, Università Piemonte Orientale) Research interests span autophagy regulation, tumor microenvironment dynamics, and epigenetic control by non-coding RNAs. He has published over 200 articles, with recent work emphasizing interdisciplinary approaches to cancer metabolism, drug delivery systems, and translational oncology. Collaborations include studies on neurodegenerative disorders, inflammatory bowel disease, and SARS-CoV-2 pathogenesis.